BlaseNicholasPoliteMD

PubMed

• MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.
  Rushabh Gujarathi, Sara Abou Azar, Joseph Tobias, Blase N Polite, Namrata Setia
  Endocrine-Related Cancer. 2024-11-01
• Point/Counterpoint #2: Current Clinical Considerations With Nonoperative Management of Rectal Cancer.
  Greeshma Rajeev-Kumar, Rohan R Katipally, Shen Li, Benjamin D Shogan, Kinga S Olortegui
  Cancer Journal. 2024-07-23
• Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.
  Eric X Chen, Petr Kavan, Mustapha Tehfe, Jeremy S Kortmansky, Michael B Sawyer
  Clinical Colorectal Cancer. 2024-06-01

Journal Articles

• Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the Ame...  
  Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Pask..., J Clin Oncol, 1/24/2017
• Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the Ame...  
  Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Pask..., CA Cancer J Clin, 1/24/2017
• Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the Ame...  
  Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Pask..., Cancer Res, 1/24/2017
• A Dynamic Equilibrium  
  Nabhan A, Polite BN, J Oncol Pract, 1/17/2017
• Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study  
  Morris VK, Salem ME, Nimeiri H, Iqbal S, Singh P, Ciombor K, Polite B, Deming D, Chan E, Wade JL, Xiao L, Bekaii-Saab T, Vence L, Blando J, Mahvash A, Foo WC, Ohaji C,..., Lancet Oncol, 1/17/2017
• Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing  
  O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R2, Polonsky TS Koyner JL, Bur..., Clin Pharmacol Ther, 1/11/2017
• Implementation of Advance Care Planning in Oncology: A Review of the Literature  
  Bestvina CM, Polite BN, J Oncol Pract, 1/6/2017
• Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer  
  Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK, Lancet Oncol, 1/1/2017
• An evaluation of psychosocial and religious belief differences in a diverse racial and socioeconomic cancer population  
  Polite BN, Cipriano-Steffens T, Hlubocky FJ, Dignam J, Ray M, Smith DM, Undevia S, Sprague E Olopade OI, Daugherty C, Fitchett G, Gehlert SJ, J Racial Ethn Health Disparities, 1/1/2017
• Evaluating Screening Colonoscopy Quality in an Uninsured Urban Population  
  Naylor K, Fritz C, Polite BN, Kim K, Prev Med Rep, 1/27/2016
• Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received  
  Schnipper LE, Davidson NE, Wollins DS, Blayney D, Dicker Ap, Ganz PA, Hoverman J, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J,. Polite BN, Ragh..., Journal of Clinical Oncology, 1/20/2016
• Genotype-guided dosing study of FOLFIRI plus bevacizumab in metastatic colorectal cancer patients  
  Toffoli G, Sharma MR, Marangon E, Posocco B, Gray E, May Q, Buonadonna A, Polite BN, Miolo G, Tabaro G, Innocenti F, Clin Cancer Res, 1/9/2016
• Oncology Pathways: Preventing a Good Idea from Going Bad  
  Polite BN, Page R, Nabhan C, JAMA Oncology, 1/4/2016
• Association between DPYD c1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147  
  Lee Am, Shi Q, Alberts SR, Sarget DJ, Sinicrope FA, Berenberg JL, Grothey A, Polite B, Chan E, Gill S, Kahlenberg MS, Nair SG, Shields Af, Goldberg RM, Diasio RB, Pharmacogenet Genomics, 1/1/2016
• Adding mFOLFOX-6 after neoadjuvant chemoradiation increases pathologic complete response in locally advanced rectal cancer: Results from a multicenter phase 2 trial wi...  
  Aguilar JG, Chow OS, Smith DD, Marcet J, Cataldo P, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt S, Stamos M, Ternent CA, Herzig D, Fichera A, Polite BN, Dietz D..., Lancet Oncol, 1/1/2015
• The Medicare Innovation Center Oncology Care Model: A Toe in the water when a plunge is needed  
  Polite BN, Miller HD, Journal of Oncology Practice, 1/1/2015
• American Society of Clinical Oncology Statement: A Framework to Assess the Value of Cancer Treatment Options  
  Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney D, Blum D, Dicker Ap, Ganz PA, Hoverman J, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J,...., Journal of Clinical Oncology, 1/1/2015
• The States as the laboratory for democracy: Is anybody paying attention and does anybody care?  
  Polite BN, Journal of Clinical Oncology, 1/1/2015
• Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide  
  O'Donnell PH, Karovic S, Karrison TG, Janisch L, Levine MR, Harris PJ, Polite BN, Cohen EE, Fleming GF, Ratain MJ, Maitland ML, Clin Cancer Res, 1/1/2015
• Metformin for Primary Colorectal Cancer Prevention in Diabetic Patients: A Case-Control Study in a US Population  
  Sehdev A, Shih YC, Vekhter B, Bissonnette M, Olopade OI, Polite BN, Cancer, 1/1/2015
• Policy Statement on 340B Drug Pricing by the American Society of Clinical Oncology  
  Policy Writing Committee, Journal of Oncology Practice, 1/15/2014
• Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma  
  Raoul JL, Park JW, Kang YK, Finn RS, Kim JS, Yeo W, Polite BN, Chao Y, Walters I, Baudelet C, Lencioni R, Liver Cancer, 1/1/2014
• The Role of Statins for Primary Prevention in on-Elderly Colorectal Cancer Patients  
  Sehdev A, Shih YC, Huo D, Vekhter B, Lyttle C, Polite BN, Anticancer Research, 1/1/2014
• Phase 1 dose-escalation study of onartuzumab as a single agent and in a combination with bevacizumab in patients with advanced solid malignancies  
  Salgia R, Patel P, Bothos L, Yu W, Bai S, Nijem I, Catenacci D, Peterson A, Ratain M, Polite BN, Mehnert J, Moss RA, Clinical Cancer Research, 1/1/2014
• Payment for Oncolytics in the United States: A History of 'Buy and Bill' and Proposals for Reform  
  Polite BN, Ward JC, Cox JV, Morton RF, Hennessy J, Page R, Conti RM, Journal of Oncology Practice, 1/1/2014
• Join now to see all

Books/Book Chapters

• Am Soc Clin Oncol Educ Book 
  Chapter: Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist 
  Page 75 - 80Polite BN, Conti RM, Ward JC2015
• Am Soc of Clin Oncol Educ Book 
  Chapter: Achieving a deeper understanding of the implemented provisions of the affordable care act. 
  Page 472 - 477Zhang SQ, Polite BN2014
• Am Soc of Clin Oncol Educ Book 
  Chapter: Achieving Health Equity in Colorectal Cancer 
  Page 169 - 173Cipriano TM, Polite BN2013
• Cancer Biology Review: A Case Based Approach 
  Chapter: "Fundamentals of DNA Synthesis." 
  Sharma M, Polite BdemosMedical, New York, NY2013
• Early Detection and Prevention of Colorectal Cancer 
  Chapter: "Eliminating Health Disparities in Colorectal Cancer Mortality" 
  Polite BNSlack, Inc.2009
• Join now to see all

Lectures

• Challenges to Access in the United States 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
• What to Expect From Washington, DC in 2018-2019 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• The OCM Journey: One Practice's Experience-Warts and All. 
  Orlando, FL - 1/1/2017
• The Bundle Jungle. 
  Orlando, FL - 1/1/2017
• MACRA: A Brave New World. 
  Milwaukee, WI - 1/1/2016
• MACRA Town Hall: Effects on your Medicare Reimbursement. 
  Chicago, IL - 1/1/2016
• The Oncology Reimbursement Landscape: The Times They are a Changin'. 
  San Francisco, CA - 1/1/2015
• The governmental view of cancer care: ASCO statement on Medicaid reform and how it may impact care delivery for HSCT patients. 
  San Diego, CA - 1/1/2015
• ASP+6 (4.3)-Is It Under Political Threat? 
  Chicago, IL - 1/1/2015
• Health Services Research Highlights: Bridging the Gap to Payment Reform. 
  Chicago, IL - 1/1/2015
• The Future of Specialty Drugs: A Policy Discussion on Treatments and Affordability. 
  Washington, DC - 1/1/2015
• State of the Science in Colorectal Cancer. 
  Cuenca, Ecuador - 1/1/2015
• Therapy for Metastatic Colorectal Cancer: State of the Science. 
  Big Sky, MT - 1/1/2015
• Role of Neoadjuvant and Adjuvant Therapy in Rectal Cancer. 
  Boston, MA - 1/1/2015
• Radiation and Chemotherapy for Locally Advanced Rectal Cancer: Does Every Patient Need Both? 
  Chicago, IL - 1/1/2015
• The Physician Payments Sunshine Act and Its Impact on Cancer Care, Research, and Education. 
  Washington, DC - 1/1/2014
• Achieving Health Equity in Colorectal Cancer: A Call to Action. 
  Chicago, IL - 1/1/2014
• Quality Based Payment Reform of Oncology Care. 
  Chicago, IL - 1/1/2014
• Implications of the Affordable Care Act on Oncology Practice and Health Equity: The Times They are a Changing. 
  Chicago, IL - 1/1/2014
• Health Care in America in 2014: Current and Future Implications of the Patient Protection and Affordable Care Act. 
  Chicago, IL - 1/1/2014
• Lessons from the ASCO/AACR/ACS/NCI Cancer Disparity Think Tank. 
  New York, NY - 1/1/2014
• Racial and Ethnic Disparities in Colorectal Cancer: Identifying the Problem and Finding Solutions. 
  1/1/2013
• Reducing Disparities in Colorectal Cancer: A Call To Action. 
  Chicago, IL - 1/1/2012
• Standardized Sociodemographic and Psychosocial Questionnaires for Alliance Trials. 
  Chicago, IL - 1/1/2012
• Disparities in Cancer Care and Outcomes: The Search for Causality. 
  Chicago, IL - 1/1/2012
• Join now to see all

Other

• Reducing Disparities in Cancer Outcomes: A Call to Action. 
  Polite BN, ASCO Daily News
  Chicago - 1/3/2011
• American Society of Clinical Oncology Position Statement On Addressing the Affordability of Cancer Drugs. 
  Polite BN, et. Al
  https://www.asco.org/sites/new-www.asco.org/files/content-files/blog-release/documents/2017-ASCO-Position-Statement-Affordability-Cancer-Drugs.pdf